Titre
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Auteur(s)
Bruder, O.
Auteure/Auteur
Schneider, S.
Auteure/Auteur
Nothnagel, D.
Auteure/Auteur
Dill, T.
Auteure/Auteur
Hombach, V.
Auteure/Auteur
Schulz-Menger, J.
Auteure/Auteur
Nagel, E.
Auteure/Auteur
Lombardi, M.
Auteure/Auteur
van Rossum, A.C.
Auteure/Auteur
Wagner, A.
Auteure/Auteur
Schwitter, J.
Auteure/Auteur
Senges, J.
Auteure/Auteur
Sabin, G.V.
Auteure/Auteur
Sechtem, U.
Auteure/Auteur
Mahrholdt, H.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1558-3597
Statut éditorial
Publié
Date de publication
2009
Volume
54
Numéro
15
Première page
1457
Dernière page/numéro d’article
1466
Langue
anglais
Notes
Publication types: Evaluation Studies ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
OBJECTIVES: During its German pilot phase, the EuroCMR (European Cardiovascular Magnetic Resonance) registry sought to evaluate indications, image quality, safety, and impact on patient management of routine CMR.
BACKGROUND: CMR has a broad range of applications and is increasingly used in clinical practice.
METHODS: This was a multicenter registry with consecutive enrollment of patients in 20 German centers.
RESULTS: A total of 11,040 consecutive patients were enrolled. Eighty-eight percent of patients received gadolinium-based contrast agents. Twenty-one percent underwent adenosine perfusion, and 11% high-dose dobutamine-stress CMR. The most important indications were workup of myocarditis/cardiomyopathies (32%), risk stratification in suspected coronary artery disease/ischemia (31%), as well as assessment of viability (15%). Image quality was good in 90.1%, moderate in 8.1%, and inadequate in 1.8% of cases. Severe complications occurred in 0.05%, and were all associated with stress testing. No patient died during or due to CMR. In nearly two-thirds of patients, CMR findings impacted patient management. Importantly, in 16% of cases the final diagnosis based on CMR was different from the diagnosis before CMR, leading to a complete change in management. In more than 86% of cases, CMR was capable of satisfying all imaging needs so that no further imaging was required.
CONCLUSIONS: CMR is frequently performed in clinical practice in many participating centers. The most important indications are workup of myocarditis/cardiomyopathies, risk stratification in suspected coronary artery disease/ischemia, and assessment of viability. CMR imaging as used in the centers of the pilot registry is a safe procedure, has diagnostic image quality in 98% of cases, and its results have strong impact on patient management.
BACKGROUND: CMR has a broad range of applications and is increasingly used in clinical practice.
METHODS: This was a multicenter registry with consecutive enrollment of patients in 20 German centers.
RESULTS: A total of 11,040 consecutive patients were enrolled. Eighty-eight percent of patients received gadolinium-based contrast agents. Twenty-one percent underwent adenosine perfusion, and 11% high-dose dobutamine-stress CMR. The most important indications were workup of myocarditis/cardiomyopathies (32%), risk stratification in suspected coronary artery disease/ischemia (31%), as well as assessment of viability (15%). Image quality was good in 90.1%, moderate in 8.1%, and inadequate in 1.8% of cases. Severe complications occurred in 0.05%, and were all associated with stress testing. No patient died during or due to CMR. In nearly two-thirds of patients, CMR findings impacted patient management. Importantly, in 16% of cases the final diagnosis based on CMR was different from the diagnosis before CMR, leading to a complete change in management. In more than 86% of cases, CMR was capable of satisfying all imaging needs so that no further imaging was required.
CONCLUSIONS: CMR is frequently performed in clinical practice in many participating centers. The most important indications are workup of myocarditis/cardiomyopathies, risk stratification in suspected coronary artery disease/ischemia, and assessment of viability. CMR imaging as used in the centers of the pilot registry is a safe procedure, has diagnostic image quality in 98% of cases, and its results have strong impact on patient management.
PID Serval
serval:BIB_6B28F497D69D
PMID
Open Access
Oui
Date de création
2010-02-09T07:28:11.532Z
Date de création dans IRIS
2025-05-21T00:27:46Z